Efficacy and safety of apatinib plus docetaxel for non-squamous non-small cell lung cancer with bone metastases.

被引：0
作者：
Zang, Aimin
Sun, Guoguo
机构：
[1] Hebei Med Univ, Affiliate Hosp, Baoding, Peoples R China
[2] Tangshan Peoples Hosp, Tangshan, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e21741
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Efficacy and safety of nintedanib and docetaxel in patients with previously treated lung non-squamous non-small cell lung cancer: a multicenter retrospective real-world analysis
    Ljubicic, Lidija
    Janzic, Urska
    Unk, Mojca
    Terglav, Ana Sophie
    Mohorcic, Katja
    Seiwerth, Fran
    Bitar, Lela
    Badovinac, Sonja
    Plestina, Sanja
    Korsic, Marta
    Kukulj, Suzana
    Samarzija, Miroslav
    Jakopovic, Marko
    RADIOLOGY AND ONCOLOGY, 2023, 57 (03) : 397 - 404
  • [22] Efficacy and Safety of Pemetrexed-Cisplatin for Advanced Non-Squamous Non-Small Cell Lung Cancer - a Galician Lung Cancer Group Study
    Senin, C.
    Varela, S.
    Huidobro, G.
    Firvida, J. L.
    Baron, F.
    Amenedo, M.
    Afonso, F. J.
    Lazaro, M.
    Campos, B.
    Casal, J.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S624 - S624
  • [23] The efficacy and safety of pemetrexed plus bevacizumab in previously treated patients with advanced non-squamous non-small cell lung cancer (ns-NSCLC)
    Ding, Lingyu
    Liu, Kejun
    Jiang, Zhelong
    Chen, Qi
    Zhou, Ningning
    Liang, Ying
    Gao, Hongfei
    Hong, Xiangchan
    Wu, Haiying
    TUMOR BIOLOGY, 2015, 36 (04) : 2491 - 2499
  • [24] Camrelizumab plus chemotherapy in advanced non-squamous non-small cell lung cancer: Treatment response, survival pattern, and safety
    Cao, Hui
    Wei, Wei
    Lu, Yang
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2022, 47 (11) : 1775 - 1782
  • [25] Successful treatment using apatinib with or without docetaxel in heavily pretreated advanced non-squamous non-small cell lung cancer: A case report and literature review
    Wu, Fengying
    Zhan, Shijia
    Gao, Guanghui
    Zhao, Jing
    Ren, Shengxiang
    Zhou, Caicun
    CANCER BIOLOGY & THERAPY, 2018, 19 (03) : 141 - 144
  • [26] The impact of prior bevacizumab on the efficacy of anlotinib in advanced non-squamous non-small cell lung cancer
    Wang, J.
    Yu, J.
    Yang, M.
    Li, A.
    Wu, F.
    Gao, G.
    Wang, L.
    Lan, H.
    Ren, S.
    JOURNAL OF THORACIC ONCOLOGY, 2025, 20 (03)
  • [27] Efficacy and Safety of Biosimilar QL1101 Compared with Avastin in Patients with Non-Squamous Non-Small Cell Lung Cancer
    Han, B.
    Li, K.
    Chu, T.
    Bi, M.
    Zhang, H.
    Yu, Y.
    Shi, J.
    Zhang, X.
    Chen, Z.
    Han, C.
    Bai, T.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S355 - S355
  • [28] Efficacy, safety, and prognostic factors of apatinib plus platinum doublet chemotherapy in advanced non-small cell lung cancer
    Xu, Jianping
    Liu, Xiaoyan
    Yang, Sheng
    Shi, Yuankai
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2022, 18 (05) : 1425 - +
  • [29] Efficacy of immune checkpoint inhibitors plus chemotherapy for TTF-1-negative non-squamous non-small cell lung cancer
    Iso, Hirokazu
    Hisakane, Kakeru
    Mikami, Erika
    Matsuki, Satoru
    Atsumi, Kenichiro
    Nagata, Kohji
    Seike, Masahiro
    Hirose, Takashi
    ANNALS OF ONCOLOGY, 2023, 34 : S1394 - S1394
  • [30] The efficacy and safety of Apatinib in the treatment of advanced non-small cell lung cancer: A retrospective trial
    Wang, Jijin
    Huang, Di
    Yang, Wenjing
    Song, Qingxu
    Jia, Yibin
    Chen, Pengxiang
    Cheng, Yufeng
    FRONTIERS IN ONCOLOGY, 2022, 12
12345